Valida Health ApS — Credit Rating and Financial Key Figures
CVR number: 41344806
Strandvejen 130 B, 2900 Hellerup
info@validahealth.dk
tel: 31402244
www.validahealth.dk
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 3 945.06 | 18 109.38 | 2 673.71 | - 645.07 |
| Employee benefit expenses | -1 124.78 | -5 544.60 | -3 226.32 | -1 511.13 |
| Total depreciation | - 169.48 | - 419.78 | -1 478.97 | |
| EBIT | 2 820.28 | 12 395.30 | - 972.39 | -3 635.17 |
| Other financial income | 10.82 | 31.05 | 2.64 | 0.31 |
| Other financial expenses | -9.48 | - 100.75 | - 189.59 | -64.78 |
| Reduction non-current investment assets | - 246.32 | -54.60 | ||
| Pre-tax profit | 2 821.62 | 12 079.28 | -1 213.93 | -3 699.63 |
| Income taxes | - 621.10 | -2 718.80 | 393.76 | 807.65 |
| Net earnings | 2 200.51 | 9 360.48 | - 820.17 | -2 891.98 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Development expenditure | 932.89 | 2 827.58 | 1 391.31 | |
| Intangible assets total | 932.89 | 2 827.58 | 1 391.31 | |
| Buildings | 50.75 | 60.03 | ||
| Machinery and equipment | 81.40 | 53.86 | 23.13 | |
| Tangible assets total | 132.15 | 53.86 | 83.17 | |
| Other receivables | 90.00 | 351.20 | 351.20 | 119.09 |
| Investments total | 90.00 | 351.20 | 351.20 | 119.09 |
| Long term receivables total | ||||
| Raw materials and consumables | 344.33 | 491.16 | 49.62 | 180.00 |
| Inventories total | 344.33 | 491.16 | 49.62 | 180.00 |
| Current trade debtors | 3 537.45 | 8 558.06 | 321.80 | 68.97 |
| Current amounts owed by group member comp. | 27.43 | |||
| Prepayments and accrued income | 333.56 | 26.25 | ||
| Current other receivables | 239.04 | 91.11 | 556.51 | 103.29 |
| Current deferred tax assets | 646.96 | 430.96 | ||
| Short term receivables total | 3 776.49 | 9 010.17 | 1 551.52 | 603.21 |
| Cash and bank deposits | 2 336.03 | 8 508.98 | 216.38 | 677.34 |
| Cash and cash equivalents | 2 336.03 | 8 508.98 | 216.38 | 677.34 |
| Balance sheet total (assets) | 6 546.85 | 19 426.55 | 5 050.16 | 3 054.13 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 53.33 |
| Shares repurchased | 2 000.00 | 6 500.00 | ||
| Other reserves | 727.65 | 2 205.51 | 1 085.22 | |
| Retained earnings | -2 000.00 | -7 027.14 | 855.48 | 2 142.26 |
| Profit of the financial year | 2 200.51 | 9 360.48 | - 820.17 | -2 891.98 |
| Shareholders equity total | 2 240.51 | 9 600.99 | 2 280.82 | 388.84 |
| Provisions | 278.50 | 376.69 | ||
| Non-current liabilities total | ||||
| Current loans from credit institutions | 14.47 | |||
| Current trade creditors | 2 946.09 | 3 724.78 | 523.54 | 331.16 |
| Short-term deferred tax liabilities | 621.10 | 2 440.31 | ||
| Other non-interest bearing current liabilities | 739.14 | 3 381.98 | 1 869.11 | 2 319.66 |
| Current liabilities total | 4 306.33 | 9 547.06 | 2 392.65 | 2 665.29 |
| Balance sheet total (liabilities) | 6 546.85 | 19 426.55 | 5 050.16 | 3 054.13 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.